基于纵向时间影像动态增强模式分析的乳腺癌新辅助化疗疗效预测

doi:10.3969/j.issn.0258-8021.2023.02.002

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (4216 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Due to its long treatment cycle, neoadjuvant chemotherapy has important clinical reference value for early and accurate prediction of the final curative effect of chemotherapy. Due to the existence of factors such as tumor heterogeneity and image partial volume effect, the traditional radiomics method makes it difficult to further improve the prediction accuracy. Features were used to predict the efficacy of neoadjuvant chemotherapy. In the experiment, images of 191 breast cancer patients collected were preprocessed to obtain images of regions of interest in tumors and glands, and radiomics features were extracted, and the longitudinal time feature change rate was calculated. The random forest model was used to predict the curative effect and combined with the AUC index to evaluate and analyze the classification performance of the model. The results showed that the best AUC of 0.791 was achieved in the task of predicting raw images before decomposition. In the image depth decomposition experiment, the distribution of longitudinal pattern changes in tumor images was more significantly different among treatment groups (P<0.01), and the best AUC of 0.888 was achieved in the prediction task of image features of different dynamic patterns. In summary, by combining the multi-regional images and longitudinal time features, compared with the images before decomposition, the images of different modes after deep decomposition improved the curative effect prediction ability based on the feature level, which was expected to provide important reference for early diagnosis of patients and program adjustment in accordance with.

Key words： breast cancer dynamic contrast-enhancement magneticresonance imaging (DCE-MRI) decomposition neoadjuvant chemotherapy longitudinal analysis

Received: 09 September 2022

PACS:

R318

Corresponding Authors: ^*E-mail: lilh@hdu.edu.cn

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Su Tianfang
	Fan Ming
	Li Lihua

Cite this article:

Su Tianfang,Fan Ming,Li Lihua. Prediction of Breast Cancer Neoadjuvant Chemotherapy Based on Dynamic Enhanced Mode Analysisof Longitudinal Time Images[J]. Chinese Journal of Biomedical Engineering, 2023, 42(2): 139-147.

URL:

http://cjbme.csbme.org/EN/10.3969/j.issn.0258-8021.2023.02.002 OR http://cjbme.csbme.org/EN/Y2023/V42/I2/139

[1] Bray F, Ferlay J, Soerjomataram I, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Global Cancer Statistics 2018.
[2] Huang J, Chan PS, Lok V, et al. Global incidence and mortality of breast cancer: a trend analysis[J]. Aging (Albany NY), 2021, 13(4): 5748.
[3] Vaidya JS, Massarut S, Vaidya HJ, et al. Rethinking neoadjuvant chemotherapy for breast cancer[J]. BMJ, 2018, 360:j5913.
[4] Xu W, Chen X, Deng F, et al. Predictors of neoadjuvant chemotherapy response in breast cancer: a review[J]. OncoTargets and Therapy, 2020, 13: 5887.
[5] Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival[J]. The Breast, 2003, 12(5): 320-327.
[6] Pinker K, Helbich TH, Morris EA. The potential of multiparametric MRI of the breast[J]. The British Journal of Radiology, 2017, 90(1069): 20160715.
[7] 李艳玲, 李洁, 曹崑, 等. 乳腺癌动态增强 MRI 特征: 非肿块样强化与肿块样强化的比较[J]. 中国医学影像技术, 2010(7): 1258-1261.
[8] Fan M, Yuan W, Liu W, et al. A deep matrix factorization framework for identifying underlying tissue-specific patterns of DCE-MRI: applications for molecular subtype classification in breast cancer[J]. Physics in Medicine & Biology, 2021, 66(24): 245013.
[9] Kim Y, Kim SH, Song BJ, et al. Early prediction of response to neoadjuvant chemotherapy using dynamic contrast-enhanced MRI and ultrasound in breast cancer[J]. Korean Journal of Radiology, 2018, 19(4): 682-691.
[10] Ashraf A, Gaonkar B, Mies C, et al. Breast DCE-MRI kinetic heterogeneity tumor markers: preliminary associations with neoadjuvant chemotherapy response[J]. Translational Oncology, 2015, 8(3): 154-162.
[11] Benetti G, Montemezzi S, Meliadò G, et al. 3T DCE-MRI radiomics for prediction of complete response to neoadjuvant chemotherapy in breast cancer[J]. Physica Medica: European Journal of Medical Physics, 2021, 92: S98.
[12] Leach MO, Morgan B, Tofts PS, et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging[J]. European Radiology, 2012, 22(7): 1451-1464.
[13] Venianaki M, Salvetti O, de Bree E, et al. Pattern recognition and pharmacokinetic methods on DCE-MRI data for tumor hypoxia mapping in sarcoma[J]. Multimedia Tools and Applications, 2018, 77(8): 9417-9439.
[14] Fan M, Zhang P, Wang Y, et al. Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer[J]. European Radiology, 2019, 29(8): 4456-4467.
[15] Fan M, Chen H, You C, et al. Radiomics of tumor heterogeneity in longitudinal dynamic contrast-enhanced magnetic resonance imaging for predicting response to neoadjuvant chemotherapy in breast cancer[J]. Frontiers in Molecular Biosciences, 2021, 8: 622219.
[16] Xue HJ, Dai X, Zhang J, et al. Deep matrix factorization models for recommendersystems[C]//Proceedings of the 26th International Conference on Artificial Intelligence. Melbourme: AAAI Press. 2017: 3203-3209.
[17] McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic[J]. Nature Medicine, 2003, 9(6): 713-725.
[18] Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies[J]. Clinical Radiology, 2001, 56(8): 607-620.
[19] 张承杰, 厉力华. 基于空间 FCM 与 MRF 方法的乳腺 MRI 序列三维病灶分割研究[J]. 中国生物医学工程学报, 2014, 33(2): 202-211.
[20] Qiu S, Jin Y, Feng S, et al. Dwarfism computer-aided diagnosis algorithm based on multimodal pyradiomics[J]. Information Fusion, 2022, 80: 137-145.
[21] Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. European Journal of Cancer, 2012, 48(4): 441-446.
[22] Vallières M, Freeman CR, Skamene SR, et al. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities[J]. Physics in Medicine & Biology, 2015, 60(14): 5471.
[23] Panth KM, Leijenaar RT, Carvalho S, et al. Is there a causal relationship between genetic changes and radiomics-based image features? Anin vivo preclinical experiment with doxycycline inducible GADD34 tumor cells[J]. Radiotherapy and Oncology, 2015, 116(3): 462-466.
[24] Tixier F, Le Rest CC, Hatt M, et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer[J]. Journal of Nuclear Medicine, 2011, 52(3): 369-378.
[25] Zhang L, Wang XH, Li L. Diagnosing autism spectrum disorder using brain entropy: A fast entropy method[J]. Computer methods and programs in biomedicine, 2020, 190: 105240.
[26] Kim SH, Lee HS, Kang BJ, et al. Dynamic contrast-enhanced MRI perfusion parameters as imaging biomarkers of angiogenesis[J]. PLoS ONE, 2016, 11(12): e0168632.
[27] 薛泰龙, 范明, 陈淑君, 等. 基于纵向时间深度网络融合的乳腺癌新辅助化疗疗效预测[J]. 中国生物医学工程学报, 41(2): 186-194.
[28] Cleary AS, Leonard TL, Gestl S A, et al. Tumour cell heterogeneity maintained by cooperating subclones in WNT-driven mammary cancers[J]. Nature, 2014, 508(7494): 113-117.